Schulman M L, Badhey M R
Surgery. 1982 Dec;92(6):1032-41.
Late results and angiographic evaluation of arm veins as arterial bypass grafts have not been reported previously. From 1969 to 1979, 68 long bypasses were performed using arm veins exclusively. There were 41 femoropopliteal bypasses, 6 peripheral aneurysm resections, 16 femorotibial bypasses, and 5 other bypasses. Sixty-four patients have been followed from 2 to 10 years. In peripheral aneurysm cases, all grafts were patent at 1 year, and long-term patency (to 127 months) was achieved in five of six patients. In the 41 femoropopliteal bypasses, cumulative life table patency rates at 1, 2, 3, and 5 years were 62%, 47%, 31%, and 31%. Unlike grafts with saphenous veins, significant graft attrition occurred in the second and third postoperative years. With femorotibial bypasses, the 1-, 2-, and 5-year life table patency rates were 43%, 31%, 15%. Late (4- to 10-year) angiographic evaluation of seven grafts revealed a pattern of graft elongation and dilation. One aneurysmal graft, partially resected 103 months after insertion, showed atheromatous changes. These results suggest that when used as infrainguinal bypass grafts, arm veins have distinct limitations and may be inferior to other presently available material. Critical review of the literature supports this conclusion.
此前尚未有关于将手臂静脉用作动脉搭桥移植物的远期结果及血管造影评估的报道。1969年至1979年期间,仅使用了手臂静脉进行了68例长段搭桥手术。其中有41例股腘动脉搭桥、6例周围动脉瘤切除术、16例股胫动脉搭桥以及5例其他搭桥手术。64例患者已接受了2至10年的随访。在周围动脉瘤病例中,所有移植物在1年时均保持通畅,6例患者中有5例实现了长期通畅(至127个月)。在41例股腘动脉搭桥手术中,1年、2年、3年和5年的累积生命表通畅率分别为62%、47%、31%和31%。与使用大隐静脉的移植物不同,显著的移植物损耗发生在术后第二年和第三年。对于股胫动脉搭桥手术,1年、2年和5年的生命表通畅率分别为43%、31%、15%。对7例移植物进行的晚期(4至10年)血管造影评估显示出移植物伸长和扩张的模式。1例动脉瘤样移植物在植入103个月后进行了部分切除,显示出动脉粥样硬化改变。这些结果表明,当用作腹股沟下搭桥移植物时,手臂静脉有明显的局限性,可能不如目前可用的其他材料。对文献的批判性回顾支持这一结论。